Specialty Pharmacy

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology, and cancer drug development.

Use of standing desks in elementary schools may reduce long-term health concerns.

Therapies that target certain gut bacteria may prevent complications and improve the efficiency of antiretroviral therapy.

Genetically engineered mice lacking a specific protein developed diabetes at a faster rate.

Experimental drug shows promise killing triple negative breast cancer cells.

Top news of the week on Specialty Pharmacy Times.

Eric Peacock, co-found and CEO of MyHealthTeams, discusses specialty pharmacy patient engagement on social media.

Top news of the day from across the health care landscape.

Atezolizumab (Tecentriq) monoclonal antibody that binds to the PD-L1 protein in non-small cell lung cancer.

New treatment for mast cell leukemia could improve quality-of-life and overall survival.

Andexanet can reverse anticoagulated-related bleeding in patients with acute major bleeding.

Several mechanisms can lead to BRAF inhibitor resistance among patients with melanoma.

Top news of the day from across the health care landscape.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of the CSI Specialty Group, discusses difficulties for an independent specialty pharmacy in the current landscape.

Lymph node staging carries a clinical significance in lung cancer patients.

Direct-acting antivirals can cure hepatitis C in most patients, but the drugs don’t eliminate complications, such as cirrhosis and liver cancer.

Specialty pharmacy data and specialty accreditations often can lead to multiple revenue streams.

The heavy reliance on MRI abnormalities and the tendency of multiple sclerosis to resemble other rare diseases leads to misdiagnoses.

United Nations Program on HIV and AIDS seeks to reach 90% of HIV patients administered antiretroviral therapy to achieve durable viral suppression.

Antibiotics have been found to alter gut microbiomes, which increases the risk of type 1 diabetes.

Rinku A. Patel, PharmD, RPh, founder and CEO of KloudScript, discusses technological advances on the horizon that may improve specialty pharmacy operations.

Top news of the day from across the health care landscape.

Research targets formation of esophageal cancer tumors.

Viekira XR consists of three oral tablets taken once a day.

Nebivolol shows promise blocking anthracycline-induced cardiotoxicity in breast cancer patients.

Pharmacokinetics of anticoagulant tecarfarin not compromised by renal function as seen with warfarin.

Success of live birth can be influenced by genetic factors during in vitro fertilization therapy.